Home
    • Plans Blog Contact
    Grown Rogue International Inc. logo

    Grown Rogue International Inc.

    GRUSF
    Last price US$0.468
    Market cap US$83.7m
    12M price change 1.74%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    Zoetis IncZTS Industry peer Amphastar PAMPH Industry peer Prestige Consumer HealthcarePBH Industry peer IQVIA Holdings IncIQV Sector peer
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    Grown Rogue International Inc. Overview

    Industry: Drug Manufacturers Specialty & Generic

    Sector: Healthcare

    Grown Rogue International Inc., a craft cannabis company, focuses on premium flower and flower-derived products. It produces a range of cultivars for consumers, which are classified as indicas, sativas, and hybrids. The company sells its products through dispensaries. Grown Rogue International Inc. was incorporated in 1978 and is headquartered in Medford, Oregon. Grown Rogue International Inc., a craft cannabis company, focuses on premium flower and flower-derived products. It produces a range of cultivars for consumers, which are classified as indicas, sativas, and hybrids. The company sells its products through dispensaries. Grown Rogue International Inc. Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for Grown Rogue International Inc. into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed Aug 04, 2026

    Quarterly result summary

    Revenue was $11.3M (+41% YoY). Net loss was -$1.5M. Net income was $1.7M.

    Revenue $11.3M +41% YoY
    Net loss -$1.5M reported
    Net income $1.7M reported
    Adjusted EBITDA $1.5M reported

    What changed

    • Revenue +41% YoY to $11.3M.

    Guidance / outlook

    the Company expects the current expansion to be substantially complete by Q4 2026, with ramp and sell-through reaching targeted levels by Q1 2027. As a result, the expansion is expected to contribute modestly to revenue and Adjusted EBITDA (non-GAAP) in 2026 and is more fully reflected in 2027 guidance.

    Earnings release Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing 10-Q Aug 05, 2026 SEC filing FORM 8-K Aug 04, 2026 SEC filing FORM 8-K May 12, 2026 Earnings release NEWS RELEASE DATED MAY 12, 2026 May 12, 2026 SEC filing 10-Q May 12, 2026 SEC filing 10-K/A May 01, 2026 SEC filing 10-K Apr 08, 2026 SEC filing FORM 8-K Apr 07, 2026 Earnings release NEWS RELEASE DATED NOVEMBER 11, 2025 Nov 12, 2025

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    Earnings Per Share

    Score 0.00/5
    Grown Rogue International Inc. earns a low score, as its Earnings Per Share (EPS) has not shown continuous growth over the last six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    In Drug Manufacturers Specialty & Generic industry , Zoetis Inc , Amphastar P , Prestige Consumer Healthcare are companies with high ratings.

    Return on Equity

    Score 1.96/5
    Grown Rogue International Inc. exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    Grown Rogue ... GRUSF US$83.7m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Net Margin

    Score 2.38/5
    Grown Rogue International Inc. olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    Grown Rogue ... GRUSF US$83.7m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Share Buyback

    In Drug Manufacturers Specialty & Generic industry , Zoetis Inc , Amphastar P , Prestige Consumer Healthcare are companies with high ratings.

    Leverage

    Score 1.96/5
    Grown Rogue International Inc. registers a lower score in the category as a result of its elevated leverage ratio over the past six years compared to the sector median value. Conversely, other companies in the same sector, including Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc have achieved high scores.
    Grown Rogue ... GRUSF US$83.7m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Reported currency
    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    Grown Rogue International Inc. logo

    Grown Rogue International Inc.

    US$0.468

    US$83.7m

    8.84%

    1.74%